Substituted piperidines as kinase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11407754
APP PUB NO 20210188854A1
SERIAL NO

16770213

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a compound represented by the following Chemical Formula 1, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, and the compound according to the present invention can be usefully used for the prevention or treatment of diseases which are associated with kinase inhibitory actions:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • DAEWOONG PHARMACEUTICAL CO., LTD

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Jeong, Seung Hwarn Daejeon, KR 2 1
Kim, Bo-Kyoung Daegu, KR 1 0
Kim, In Woo Seoul, KR 44 148
Kim, Nam Youn Gyeonggi-do, KR 6 4
Lee, Jun Hee Seoul, KR 107 514

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Feb 9, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 9, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 9, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00